Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair

Regenerative Medicine

Volumn 5, Issue 2, 2010, Pages 231-244

  Rufaihah, Abdul Jalil ^a,b   Haider, Husnain Khawaja ^c   Heng, Boon Chin ^d   Ye, Lei ^b   Tan, Ru San ^e   Toh, Wei Seong ^d   Tian, Xian Feng ^d   Sim, Eugene Kwang Wei ^b,e   Cao, Tong ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DEPARTMENT OF CARDIOLOGY   (Singapore)

Author keywords

Adenovirus; Angiogenesis; CD133; Embryonic stem cells; Transfectionn VEGF

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CULTURE MEDIUM; DENSITY; DISEASE MODEL; ECHOCARDIOGRAPHY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT OUTCOME; UPREGULATION; VIRUS PARTICLE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD; APOPTOSIS; BLOOD VESSELS; CELL LINE; CELL SHAPE; CELL SURVIVAL; CYTOKINES; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HEART FUNCTION TESTS; HUMANS; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; PLURIPOTENT STEM CELLS; RATS; STEM CELL TRANSPLANTATION; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 77949401715     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.83     Document Type: Article

References (56)

1. Reubinoff BE, Pera MF, Fong CY et al.: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404 (2000).
2. Thomson JA, Itskovitz-Eldor J, Shapino SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
3. Carpenter MK, Inokuma MS, Denham J et al.: Enrichment of neurons and neural precursors from human embryonic stem cells. Exp. Neurol. 172, 383-397 (2001).
4. Toh WS, Yang Z, Liu H et al.: Effects of BMP2 and culture conditions on the extent of chondrogenesis from human embryonic stem cells. Stem Cells 25, 950-960 (2007).
5. Kaufman DS, Hanson ET, Lewis RL, et al.: Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 98, 10716-10721 (2001).
6. Mummery C, Ward D, van den Brink CE et al.: Cardiomyocytes differentiation of mouse and human embryonic stem cells. J. Anat. 200, 233-242 (2002).
7. Kehat I, Kenyagin-Karsetin D, Snir M et al.: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414 (2001).
8. Gerecht-Nir S, Ziskind A, Cohen S et al.: Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab. Invest. 83, 1811-1820 (2003).
9. Levenberg S, Golub JS, Amit M et al.: Endothelial cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 99, 4391-4396 (2002).
10. Guillaume DJ, Johnson MA, Li XJ et al.: Human embryonic stem cell-derived neural precursors develop into neurons and integrate into the host brain. J. Neurosci. Res. 84(6), 1165-1176 (2006).
11. Caspi O, Huber I, Kehat I et al.: Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50(19), 1884-1893 (2007).
12. Oyamada N, Itoh H, Sone M et al.: Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J. Transl. Med. 30(6), 54-67 (2008).
13. Heng BC, Cao T, Haider HK et al.: An overview and synopsis of techniques for directing stem cell differentiation in vitro. Cell Tissue Res. 315(3), 291-303 (2004).
14. Pick M, Azzola L, Mossman A, Stanley EG, Elefanty AG: Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4 vascular endothelial growth factor, stem cell factor, and fbroblast growth factor 2 in hematopoiesis. Stem Cell 25(9), 2206-2214 (2007).
15. Heng BC, Cao T: Milieu-based versus gene-modulatory strategies for directing stem cell differentiation-major issue of contention in transplantation medicine. In vitro Cell. Dev. Biol. Anim. 42(3-4), 51-53 (2006).
16. Räty JK, Lesch HP, Wirth T, Ylä-Herttuala S: Improving safety of gene therapy. Curr. Drug Saf. 3(1), 46-53 (2008).
17. Heng BC, Hong YH, Cao T: Modulating gene expression in stem cells without recombinant DNA and permanent genetic modifcation. Cell Tissue Res. 321(2), 147-150 (2005).
18. Zwaka TP, Thomson JA: Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21, 319-321 (2003).
19. Siemen H, Nix M, Endl E et al.: Nucleofection of human embryonic stem cells. Stem Cells Dev. 14, 378-383 (2005).
20. Koumbi D, Clement JC, Sideratou Z et al.: Factors mediating lipofection potency of a series of cationic phosphonolipids in human cell lines. Biochim. Biophys. Acta 1760(8), 1151-1159 (2006).
21. Kawabata K, Sakurai F, Koizumi N et al.: Adenovirus vector-mediated gene transfer into stem cells. Mol. Pharm. 3(2), 95-103 (2006).
22. Gropp M, Itsykson P, Singer O et al.: Stable genetic modifcation of human embryonic stem cells by lentiviral vectors. Mol. Ther. 7(2), 281-287 (2003).
23. Clements MO, Godfrey A, Crossley J et al.: Lentiviral manipulation of gene expression in human adult and embryonic stem cells. Tissue Eng. 12(7), 1741-1751 (2006).
24. Kawabata K, Sakurai F, Koizumi N, Hayakawa T, Mizuguchi H: Adenovirus vector-mediated gene transfer into stem cells. Mol. Pharm. 3(2), 95-103 (2006).
25. Wilber A, Linehan JL, Tian X, Woll PS et al.: Effcient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer. Stem Cells 25(11), 2919-2927 (2007).
26. Ma Y, Ramezani A, Lewis R et al.: High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21, 111-117 (2003).
27. Lakshmipathy U, Pelacho B, Sudo K, et al.: Effcient transfection of embryonic and adult stem cells. Stem Cells 22, 531-543 (2004).
28. Brokhman I, Pomp O, Shaham L et al.: Genetic modifcation of human embryonic stem cells with adenoviral vectors: differences of infectability between lines and correlation of infectability with expression of the coxsackie and adenovirus receptor. Stem Cells Dev. 18(3), 447-456 (2008).
29. Risau W, Flamme I: Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11, 73-91 (1995).
30. Risau W: Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
31. Jujo K, Ii M, Losordo DW: Endothelial progenitor cells in neovascularization of infarcted myocardium. J. Mol. Cell. Cardiol. 45(4), 530-544 (2008).
32. Kawamoto A, Tkebuchava T, Yamaguchi J et al.: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107(3), 461-468 (2003).
33. Takahashi H, Shibuya M: The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond.)109(3), 227-241 (2005).
34. Roy H, Bhardwaj S, Yla-Herttuala S: Biology of vascular endothelial growth factors. FEBS Lett. 580(12), 2879-2887 (2006).
35. Miller-Kasprzak E, Jagodzinski PP: Endothelial progenitor cells as a new agent contributing to vascular repair. Arch. Immunol. Ther. Exp. (Warsz.) 55(4), 247-259 (2007).
36. Shmelkov SV, St Clair R, Lyden D et al.: AC133/CD133/Prominin-1. Int. J. Biochem. Cell Biol. 37(4), 715-719 (2005).
37. Urbich C, Dimmeler S: Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95(4), 343-353 (2004).
38. Hristov M, Weber C: Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell. Mol. Med. 8(4), 498-508 (2004).
39. Tatsis N, Ertl HC: Adenoviruses as vaccine vectors. Mol. Ther. 10, 616-629 (2004).
40. Ye L, Haider HKH, Jiang S, et al.: In vitro functional assessment of human skeletal myoblasts after transduction with adenoviral bicistronic vector carrying human VEGF165 and angiopoietin-1. J. Heart Lung Transplant. 24, 1393-1402 (2005).
41. Jiang S, Haider HKH, Idris NM et al.: Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ. Res. 99(7), 776-784 (2006).
42. Takahashi H, Shibuya M: The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (Lond.) 109(3), 227-241 (2005).
43. Rufaihah AJ, Haider HK, Heng BC et al.: Directing endothelial differentiation of human embryonic stem cells via transduction with an adenoviral vector expressing the VEGF(165) gene. J. Gene Med. 9(6), 452-461 (2007).
44. Wang I, Huang I: Adenovirus technology for gene manipulation and functional studies. Drug Discov. Today 5, 10-16 (2000).
45. Benihoud K, Yeh P, Perricaudet M: Adenovirus vectors for gene delivery. Curr. Opin. Biotechnol. 10, 440-447 (1999).
46. Olivetti G, Capasso JM, Meggs LG et al.: Cellular basis of chronic ventricular remodeling after MI in rats. Circ. Res. 68(3), 856-869 (1991).
47. Shi Q, Rafi S, Wu MH et al.: Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367 (1998).
48. Kawamoto A, Gwon HC, Iwaguro H et al.: Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637 (2001).
49. Kalka C, Masuda H, Takahashi T et al.: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl Acad. Sci. USA 28, 3422-3427 (2000).
50. Kocher AA, Schuster MD, Szabolcs MJ et al.: Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocytes apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436 (2001).
51. Takashi E, Ashraf M: Pathologic assessment of myocardial necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J. Mol. Cell. Cardiol. 32, 209-224 (2000).
52. Gehling UM, Ergün S, Schumacher U et al.: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95, 3106-3112 (2000).
53. Kamihata H, Matsubara H, Nishiue T et al.: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands and cytokines. Circulation 104, 1046-1052 (2001).
54. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Phillips MI: Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann. Thorac. Surg. 80, 229-237 (2005).
55. Zhang S, Zhang P, Guo J et al.: Enhanced cytoprotection and angiogenesis by bone marrow cell transplantation may contribute to improved ischemic myocardial function. Eur. J. Cardiothorac. Surg. 25, 188-195 (2004).
56. Heba G, Krzeminski T, Pore M, Grzyb J, Ratajska A, Dembinska-Kiec A: The time course of tumour necrosis factor-a, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. J. Vasc. Res. 38, 288-300 (2001).